speb/financial-data huggingface dataset:
CVS.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 3603000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 3603000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 1858000000.00
CVS.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 3581000000.00
CVS.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 1021000000.00
CVS.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 1897000000.00
CVS.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 0.00
CVS.TO income_statement (quarterly, 2025-06-30) — Operating Income: 2381000000.00
CVS.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 98915000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1267000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 3378000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 6160000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1088000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 272000000.00
CVS.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 29000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 26224000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Other Investments: 4179000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 5214000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 9551000000.00
CVS.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 29000000.00
CVS.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 11212000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Other Payable: 41609000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 28337000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 24301000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 2386000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Payables: 58867000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 81968000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CVS.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 1647000000.00
CVS.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 47000000.00
CVS.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -119000000.00
CVS.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -3634000000.00
CVS.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -607000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 40651000000.00
CVS.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 85322000000.00
CVS.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1171000000.00
CVS.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -19000000.00
CVS.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 63936000000.00
CVS.TO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 3332000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 1785000000.00
CVS.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 136000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 77379000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -40048000000.00
CVS.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CVS.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 634000000.00
CVS.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.39
CVS.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 258343000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 134669000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 82724000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 77551000000.00
CVS.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 96534000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 180792000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 182694000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 86630000000.00
CVS.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 2381000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 518000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 36849000000.00
CVS.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: -18513000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 11288000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 102871000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 17764000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 16099000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 25857000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 12025000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -698000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 15916000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 50181000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 9098000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 11232000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -846000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1382000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -2087000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 796000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 1221000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: -1653000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 381000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 1110000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 1989000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1989000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -3398000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1571000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -3398000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2673000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Commercial Paper: 1247000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 50181000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -846000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 72928000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
CVS.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 89065000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 23415000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 77109000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1909000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 5328000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 7237000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 92695000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -157000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: -157000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Defined Pension Benefit: 1934000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1134000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1134000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -3975000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — EBIT: -2698000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — EBITDA: -1564000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 1934000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 9352000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1382000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 98000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: -483000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 483000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 416000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Goodwill: 85478000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 111462000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 28109000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 13806000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 1367000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 5725000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 784000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 784000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 18962000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 138764000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -2087000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 27224000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 31553000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 3969000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 14007000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 60508000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 74515000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 3969000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -2847000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Minority Interest: 182000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Minority Interests: 15000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -290000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 56738000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Net Income: -3975000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -3975000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -3990000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -3975000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -3975000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -3990000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -3990000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -784000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -1085000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -671000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 1122000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -784000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 18000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -14000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 28109000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -698000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -1793000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -38534000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 3547000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 3547000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 1934000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 3678000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 166180000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 796000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -483000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Operating Income: 2518000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 102871000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1270000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 3058000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 4081000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1096000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 416000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: -5216000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 25984000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Other Investments: 4329000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 5160000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 9526000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 26000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 11288000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Other Payable: 43183000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 28109000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 27758000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 2134000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Payables: 60947000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 84362000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CVS.TO income_statement (quarterly, 2025-09-30) — Pretax Income: -3482000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 117000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -290000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -3859000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -698000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 43857000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 89065000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1134000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -3719000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
CVS.TO income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 0.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 59107000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 2774000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 1786000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: -5242000000.00
CVS.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 138000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 72928000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -38534000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -1100820000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 508000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CVS.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 255327000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 133436000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 81752000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 73110000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 100353000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 182217000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 178218000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 89522000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -3207000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -5242000000.00
CVS.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -5242000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 516000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 36776000000.00
CVS.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: -15586000000.00
CVS.TO income_statement (annual, 2025-12-31) — +Operating Expense: 44977000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 11455000000.00
CVS.TO income_statement (annual, 2025-12-31) — +Total Revenue: 402067000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 105693000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 17641000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 17641000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 16316000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 16316000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -24744000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -24744000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 5725000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
CVS.TO balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 26721000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 26721000000.00
CVS.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 6958817258.00
CVS.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 6975294331.00
CVS.TO income_statement (annual, 2025-12-31) — Basic EPS: 0.25
CVS.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.42
CVS.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 8884000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 9352000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 4593000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 4593000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -2832000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -784000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 15380000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 15380000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 50402000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 50402000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 8453000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 8453000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 10598000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 10598000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -3397000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -845000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4940000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2032000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -5871000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1998000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 10639000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3390000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: 3855000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -1197000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -1267000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: -285000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -2593000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -2005000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 2013000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -855000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Change In Payable: 3871000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: -1915000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 3871000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -1915000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -3498000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 4039000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -1474000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -1021000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -3498000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 4039000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -172000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -640000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Commercial Paper: 0.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Commercial Paper: 0.00
CVS.TO balance_sheet (annual, 2025-12-31) — Common Stock: 50402000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 50402000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -3397000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -845000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 75214000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 75214000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
CVS.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 346705000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 92126000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 22387000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 22387000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Current Assets: 74714000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 74714000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1737000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1737000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Current Debt: 4068000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 4068000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 5805000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 5805000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 88692000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 88692000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 102000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 542000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 102000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 542000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 1994000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 1994000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 4606000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1147000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 4606000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1147000000.00
CVS.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 6980786689.00
CVS.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 7013740836.00
CVS.TO income_statement (annual, 2025-12-31) — Diluted EPS: 0.25
CVS.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.42
CVS.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1768000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2943000000.00
CVS.TO income_statement (annual, 2025-12-31) — EBIT: 5255000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — EBIT: 2141000000.00
CVS.TO income_statement (annual, 2025-12-31) — EBITDA: 9861000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — EBITDA: 3288000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Employee Benefits: 1994000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 1994000000.00
CVS.TO cash_flow (annual, 2025-12-31) — End Cash Position: 8712000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 8712000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -4940000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -2032000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 7807000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 2606000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -247000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
CVS.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Business: 483000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: 0.00
CVS.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 0.00
CVS.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 406000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 406000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Goodwill: 85478000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 85478000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 110986000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 110986000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 52800000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 52800000000.00
CVS.TO income_statement (annual, 2025-12-31) — Gross Profit: 55362000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 13567000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 1376000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 1376000000.00
CVS.TO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 5725000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
CVS.TO income_statement (annual, 2025-12-31) — Interest Expense: 3119000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 787000000.00
CVS.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 3119000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 787000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Inventory: 19246000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 19246000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 139784000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 139784000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -5871000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1998000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 28097000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 28097000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 32669000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 32669000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 3969000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
CVS.TO balance_sheet (annual, 2025-12-31) — Land And Improvements: 1809000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 1809000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Leases: 6812000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Leases: 6812000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 13643000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 13643000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 60502000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 60502000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 74145000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 74145000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 3969000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
CVS.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -3629000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -20000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 24613000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 24613000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Minority Interest: 168000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 168000000.00
CVS.TO income_statement (annual, 2025-12-31) — Minority Interests: 40000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Minority Interests: 20000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -436000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -7000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CVS.TO balance_sheet (annual, 2025-12-31) — Net Debt: 56117000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 56117000000.00
CVS.TO income_statement (annual, 2025-12-31) — Net Income: 1768000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Net Income: 2943000000.00
CVS.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1768000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2943000000.00
CVS.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 1728000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2923000000.00
CVS.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1768000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2943000000.00
CVS.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1768000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2943000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1728000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 2923000000.00
CVS.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 1728000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2923000000.00
CVS.TO income_statement (annual, 2025-12-31) — Net Interest Income: -3119000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -787000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -2629000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -1224000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -1779000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -1267000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 340000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -20000000.00
CVS.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -3119000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -787000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -158000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -6000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 26000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 17000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Net PPE: 28056000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 28056000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -2832000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -784000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -2119000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -1247000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -35772000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -35772000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 3832000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 3832000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 3832000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 3832000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1994000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1994000000.00
CVS.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 15103000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 3288000000.00
CVS.TO income_statement (annual, 2025-12-31) — Normalized Income: 6008778000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 2943000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 10639000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 3390000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -247000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 0.00
CVS.TO income_statement (annual, 2025-12-31) — Operating Income: 10385000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Operating Income: 2112000000.00
CVS.TO income_statement (annual, 2025-12-31) — Operating Revenue: 402067000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 105693000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1271000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1271000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 5091000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 5091000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 4068000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 4068000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 1116000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1116000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 406000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 406000000.00
CVS.TO income_statement (annual, 2025-12-31) — Other Income Expense: -5130000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 29000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 25508000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 25508000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Other Investments: 4572000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Other Investments: 4572000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: -336000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 5119000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 5119000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 9493000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 9493000000.00
CVS.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 112000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 29000000.00
CVS.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 44977000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 11455000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Other Payable: 41743000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 41743000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Other Properties: 14973000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 14973000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 23463000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 23463000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 2145000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 2145000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Payables: 59384000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Payables: 59384000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 81771000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 81771000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CVS.TO income_statement (annual, 2025-12-31) — Pretax Income: 2136000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 1354000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 394000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 86000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CVS.TO cash_flow (annual, 2025-12-31) — Purchase Of Business: -436000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -7000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -15012000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -3967000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -2832000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -784000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Receivables: 39779000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 39779000000.00
CVS.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 346705000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 92126000000.00
CVS.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 4606000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1147000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -5748000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1267000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
CVS.TO income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
CVS.TO income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
CVS.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 61196000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 61196000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Sale Of Investment: 12383000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 2743000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Share Issued: 1787000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 1787000000.00
CVS.TO cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 0.00
CVS.TO cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -2119000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: -1247000000.00
CVS.TO income_statement (annual, 2025-12-31) — Special Income Charges: -5242000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
CVS.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 535000000.00
CVS.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 135000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 75214000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 75214000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: -35772000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -35772000000.00
CVS.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -1001222000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CVS.TO income_statement (annual, 2025-12-31) — Tax Provision: 408000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Tax Provision: -1569000000.00
CVS.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.19
CVS.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CVS.TO balance_sheet (annual, 2025-12-31) — Total Assets: 253538000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 253538000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 135716000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 135716000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Total Debt: 79950000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 79950000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 75382000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 75382000000.00
CVS.TO income_statement (annual, 2025-12-31) — Total Expenses: 391682000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 103581000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 178156000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 178156000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 178824000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 178824000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 89464000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 89464000000.00
CVS.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 4660000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 2112000000.00
CVS.TO income_statement (annual, 2025-12-31) — Total Unusual Items: -5242000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
CVS.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -5242000000.00
CVS.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CVS.TO balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 516000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 516000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Treasury Stock: 36790000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 36790000000.00
CVS.TO balance_sheet (annual, 2025-12-31) — Working Capital: -13978000000.00
CVS.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: -13978000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 10944000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 100426000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 16922000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 20144000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 26287000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 6991771405.00
CVS.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.42
CVS.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 8712000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -849000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 15234000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 50679000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 9542000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 11802000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -847000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -2318000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -874000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 4249000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -562000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: 1476000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 479000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -196000000.00